Hemant Surgical Industries Ltd. (HSIL) 52 Week High Streak: Second Straight Session Near One-Year Peak

Hemant Surgical Industries Ltd. 52 Week High Streak is now into its second straight session, with HSIL trading within 2% of its one-year peak and advancing 1.39% across the streak. The latest move kept Hemant Surgical Industries Ltd. near its 52-week high at Rs 619, while the latest Univest data confirms the repeated-high pattern but does not establish a company-specific catalyst for the continued move.

HSIL was at Rs 603.4 in the previous session, opened at Rs 618.9 and touched Rs 618.9 to Rs 619 during the day so far, leaving the price tight to the upper end of the range. Hemant Surgical Industries Ltd. 52 Week High Streak is therefore a streak-reading story rather than a one-day breakout story, and the repeated-high pattern matters because it shows price persistence over multiple sessions rather than a single print near the peak. The company’s market capitalisation stands at Rs 887.52 crore.

Hemant Surgical Industries Ltd. 52 Week High Streak: Consecutive High Analysis

Metric	Value
Current Price	Rs 619
Previous Close	Rs 603.4
Today's Move	+Rs 15.6 (+2.59%)
Open	Rs 618.9
High	Rs 619
Low	Rs 618.9
Market Capitalisation	Rs 887.52 crore

Hemant Surgical Industries Ltd. (HSIL) traded at Rs 619 versus the previous close of Rs 603.4, a rise of 2.59%. The stock opened at Rs 618.9, reached a high of Rs 619 and touched a low of Rs 618.9.

HSIL share price today is trading at Rs 619, up Rs 15.6 or 2.59% from the previous session’s Rs 603.4. The move matters because Hemant Surgical Industries Ltd. 52 Week High Streak is being built around repeated trading near the one-year peak, not just a brief touch. The day opened at Rs 618.9 and has moved between Rs 618.9 and Rs 619, which places the price very near the upper band of the day’s range as of 06 October 2026 at 9:22 AM IST. In that context, the latest HSIL share price update keeps the stock in view for readers following stocks at one year high today and stocks hitting 52 week highs.

The current market capitalisation of Rs 887.52 crore places Hemant Surgical Industries Ltd. in the small-company end of the healthcare universe by market value, but the number itself does not say anything about quality or trajectory. For readers tracking HSIL stock news, the important point is that the share price has not simply spiked once; it has stayed near the 52-week high for a second straight session. That repeated pattern is different from a single-day move and is the main reason this Hemant Surgical Industries Ltd. 52 Week High Streak deserves separate attention.

What the Repeated 52-Week Highs Show

Hemant Surgical Industries Ltd. 52 Week High Streak shows that the stock has remained close to its 52-week high for a second straight session, with the cumulative move across the streak at 1.39%. That is the key differentiator from a one-session breakout: the price has stayed near the same elevated zone across consecutive trading sessions, which makes the pattern more persistent than a single print near the yearly high.

At this stage, the latest Univest figures confirm the price pattern, but they do not establish a company-specific catalyst for the continued move. For readers searching HSIL stock performance or HSIL share price today, that distinction matters. A repeated near-high pattern can attract attention on screens such as the “Stocks Hitting 52 Week Highs” category and the “Stocks In News Today” category, but the article should still be read as a market-pattern update rather than a catalyst story. HSIL’s new one year high again narrative is therefore best understood as a streak-led event, not as evidence of a fresh fundamental development.

Hemant Surgical Industries Ltd. (HSIL) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 887.52 crore
P/E Ratio	48.22x
P/B Ratio	6.1x
ROE	12.73%
ROCE	13.58%
EPS	Rs 12.51
Book Value Per Share	Rs 98.98
Dividend Yield	0%

Hemant Surgical Industries Ltd. (HSIL) fundamental metrics show P/E 48.22x, P/B 6.1x, ROE 12.73%, ROCE 13.58%. These figures provide context only and are not a buy or sell signal.

Hemant Surgical Industries Ltd. has a market capitalisation of Rs 887.52 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 48.22x, P/B at 6.1x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 12.73% and ROCE of 13.58%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 12.51, book value per share of Rs 98.98, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 30.47x, median ROE of 14.07%, median ROCE of 15.05%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Medical Equipment/Supplies/Accessories
Benchmark Scope	same industry
Company P/E Ratio	48.22x
Benchmark Median P/E	30.47x
Benchmark Average P/E	85.54x
Benchmark P/E Range	0x to 957.63x
Company P/B Ratio	6.1x
Benchmark Median P/B	3.74x
Company ROE	12.73%
Benchmark Median ROE	14.07%
Company ROCE	13.58%
Benchmark Median ROCE	15.05%
Company Market Capitalisation	Rs 887.52 crore
Benchmark Median Market Cap	Rs 177.58 crore

Hemant Surgical Industries Ltd. (HSIL) is classified under sector: Healthcare and industry: Medical Equipment/Supplies/Accessories.

Hemant Surgical Industries Ltd. (HSIL) has a P/E ratio of 48.22x, which is above the benchmark median of 30.47x, a difference of +58.25%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Hemant Surgical Industries Ltd. (HSIL) has a ROE of 12.73%, which is below the benchmark median of 14.07%, a difference of -9.52%. Hemant Surgical Industries Ltd. (HSIL) has a ROCE of 13.58%, which is below the benchmark median of 15.05%, a difference of -9.77%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
LAXMI DENTAL LIMITED	LAXMIDENTL	1,065.92	33.92	4.27	11.95	13.29
Osel Devices Ltd.	OSELDEVICE	650.93	22.26	5.94	30.09	31.15
3B Blackbio Dx Ltd.	3BBLACKBIO	1,420.26	25.2	4.2	20.22	25.9
Q-LINE BIOTECH LIMITED	QLINE	1,542.23	27.78	6.11	25.55	22.23
Prevest Denpro Ltd.	PREVEST	452.57	21.03	3.5	17.79	24.21

Hemant Surgical Industries Ltd. (HSIL) has a P/E ratio of 48.22x compared with the displayed peer median of 25.2x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 12.73% compares with a peer median of 20.22% across the companies shown in the table. ROCE stood at 13.58% versus the displayed peer median of 24.21%, providing a capital-efficiency comparison. Hemant Surgical Industries Ltd. (HSIL) has a market capitalisation of Rs 887.52 crore. Among the 5 peers shown, 3 have a larger market capitalisation.

Why Investors Are Watching Hemant Surgical Industries Ltd.

• Hemant Surgical Industries Ltd. 52 Week High Streak has now extended to a second straight session near the one-year peak.
• The cumulative move across the streak is 1.39%, keeping HSIL Share Price close to the recent high zone.
• HSIL Share Price is trading at Rs 619, above the previous session’s Rs 603.4.
• HSIL Fundamental Analysis shows a P/E of 48.22 and a P/B of 6.1 against a healthcare peer sample.
• The stock remains one of the Healthcare names that can appear in stocks at one year high today screens.

About Hemant Surgical Industries Ltd.

Hemant Surgical Industries Ltd. is a listed healthcare company in the Medical Equipment/Supplies/Accessories industry, tracked on NSE and BSE. HSIL Share Price movements often draw attention because the company sits within a segment where valuation, returns and peer comparison can shift meaningfully even when the broader market is not making a large move. The current market capitalisation is Rs 887.52 crore, and the latest Univest figures show EPS of Rs 12.51, book value of Rs 98.98, ROE of 12.73% and ROCE of 13.58%.

For readers following HSIL Company News or HSIL Stock News, the useful lens is to watch how the share price behaves relative to its one-year peak, how it compares with listed peers, and whether future company updates change the valuation conversation.

Frequently Asked Questions

What does Hemant Surgical Industries Ltd. 52 Week High Streak mean?

It means HSIL has traded within 2% of its 52-week high for a second straight session. The phrase focuses on the repeated proximity to the yearly peak, not on a fresh record being set.

How much has HSIL moved across the streak?

The cumulative move across the streak is 1.39%. That figure captures the full repeated-high period rather than only the latest intraday change.

Did Hemant Surgical Industries Ltd. set a new 52-week high today?

The latest figures show the stock trading near its 52-week high, not necessarily making a new high today. The article treats it as a near-high streak event rather than a confirmed breakout print.

What is HSIL share price today?

HSIL share price is Rs 619 in the latest update. It is above the previous session’s Rs 603.4 and remains near the one-year peak.

Is Hemant Surgical Industries Ltd. expensive compared with peers?

On the given sample, HSIL looks richer than the industry median on both P/E and P/B. Its return ratios are also slightly below the peer medians, so the valuation looks premium against that comparison set.

Which sector and industry does HSIL belong to?

HSIL belongs to Healthcare and sits in the Medical Equipment/Supplies/Accessories industry. That placement helps frame the stock against other listed healthcare names with different valuation and return profiles.

What should investors monitor next in HSIL stock news?

Investors should track whether the share price keeps staying near the 52-week high, whether the premium valuation persists, and whether future company updates alter the present streak-led picture. The current pattern alone does not confirm a catalyst.

Why is this different from a one-day 52-week high story?

This article focuses on a repeated near-high pattern across consecutive sessions. A one-day 52-week high story is about a single session; a streak story asks why the stock has stayed near the peak for longer.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.